Proactiveinvestors USA & Canada Q BioMed Inc https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Q BioMed Inc RSS feed en Sun, 18 Aug 2019 06:00:58 -0400 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[News - Q BioMed on track with commercialization of non-opioid metastatic cancer pain drug ]]> https://www.proactiveinvestors.com/companies/news/223763/q-biomed-on-track-with-commercialization-of-non-opioid-metastatic-cancer-pain-drug-223763.html Thu, 11 Jul 2019 09:24:00 -0400 https://www.proactiveinvestors.com/companies/news/223763/q-biomed-on-track-with-commercialization-of-non-opioid-metastatic-cancer-pain-drug-223763.html <![CDATA[News - Q BioMed files for FDA's Orphan Drug status for its pediatric autism drug ]]> https://www.proactiveinvestors.com/companies/news/223067/q-biomed-files-for-fda-s-orphan-drug-status-for-its-pediatric-autism-drug-223067.html Fri, 28 Jun 2019 08:48:00 -0400 https://www.proactiveinvestors.com/companies/news/223067/q-biomed-files-for-fda-s-orphan-drug-status-for-its-pediatric-autism-drug-223067.html <![CDATA[News - Q BioMed to apply for Orphan Drug status with FDA, European regulators for its pediatric autism drug ]]> https://www.proactiveinvestors.com/companies/news/221493/q-biomed-to-apply-for-orphan-drug-status-with-fda-european-regulators-for-its-pediatric-autism-drug-221493.html Tue, 04 Jun 2019 10:31:00 -0400 https://www.proactiveinvestors.com/companies/news/221493/q-biomed-to-apply-for-orphan-drug-status-with-fda-european-regulators-for-its-pediatric-autism-drug-221493.html <![CDATA[News - Q BioMed discovers two key biomarkers in study of pediatric nonverbal autism ]]> https://www.proactiveinvestors.com/companies/news/312972/q-biomed-discovers-two-key-biomarkers-in-study-of-pediatric-nonverbal-autism-12972.html Thu, 11 Apr 2019 12:00:00 -0400 https://www.proactiveinvestors.com/companies/news/312972/q-biomed-discovers-two-key-biomarkers-in-study-of-pediatric-nonverbal-autism-12972.html <![CDATA[News - Q BioMed uncovers first biomarkers for pediatric nonverbal autism ]]> https://www.proactiveinvestors.com/companies/news/218331/q-biomed-uncovers-first-biomarkers-for-pediatric-nonverbal-autism-218331.html Wed, 10 Apr 2019 09:07:00 -0400 https://www.proactiveinvestors.com/companies/news/218331/q-biomed-uncovers-first-biomarkers-for-pediatric-nonverbal-autism-218331.html <![CDATA[News - Q BioMed gains on outlook for near-term development and approval of glaucoma candidates ]]> https://www.proactiveinvestors.com/companies/news/217343/q-biomed-gains-on-outlook-for-near-term-development-and-approval-of-glaucoma-candidates-217343.html Wed, 27 Mar 2019 09:58:00 -0400 https://www.proactiveinvestors.com/companies/news/217343/q-biomed-gains-on-outlook-for-near-term-development-and-approval-of-glaucoma-candidates-217343.html <![CDATA[News - Q BioMed and Mannin Research to develop GDF15 biomarker glaucoma diagnostic kit with McMaster University ]]> https://www.proactiveinvestors.com/companies/news/216754/q-biomed-and-mannin-research-to-develop-gdf15-biomarker-glaucoma-diagnostic-kit-with-mcmaster-university-216754.html Tue, 19 Mar 2019 07:41:00 -0400 https://www.proactiveinvestors.com/companies/news/216754/q-biomed-and-mannin-research-to-develop-gdf15-biomarker-glaucoma-diagnostic-kit-with-mcmaster-university-216754.html <![CDATA[News - Q BioMed licenses significant biomarker to diagnose glaucoma ]]> https://www.proactiveinvestors.com/companies/news/312568/q-biomed-licenses-significant-biomarker-to-diagnose-glaucoma-12568.html Tue, 12 Mar 2019 09:35:00 -0400 https://www.proactiveinvestors.com/companies/news/312568/q-biomed-licenses-significant-biomarker-to-diagnose-glaucoma-12568.html <![CDATA[News - Q BioMed licenses novel biomarker for monitoring glaucoma severity from Washington University ]]> https://www.proactiveinvestors.com/companies/news/216202/q-biomed-licenses-novel-biomarker-for-monitoring-glaucoma-severity-from-washington-university-216202.html Mon, 11 Mar 2019 10:27:00 -0400 https://www.proactiveinvestors.com/companies/news/216202/q-biomed-licenses-novel-biomarker-for-monitoring-glaucoma-severity-from-washington-university-216202.html <![CDATA[News - Q BioMed's Technology partner Mannin Research forges research collaboration with McMaster University for Glaucoma drug MAN-01 ]]> https://www.proactiveinvestors.com/companies/news/213357/q-biomed-s-technology-partner-mannin-research-forges-research-collaboration-with-mcmaster-university-for-glaucoma-drug-man-01-213357.html Fri, 25 Jan 2019 09:01:00 -0500 https://www.proactiveinvestors.com/companies/news/213357/q-biomed-s-technology-partner-mannin-research-forges-research-collaboration-with-mcmaster-university-for-glaucoma-drug-man-01-213357.html <![CDATA[News - QBioMed appoints Yale psychologist to advisory committee ]]> https://www.proactiveinvestors.com/companies/news/212710/qbiomed-appoints-yale-psychologist-to-advisory-committee-212710.html Wed, 16 Jan 2019 09:22:00 -0500 https://www.proactiveinvestors.com/companies/news/212710/qbiomed-appoints-yale-psychologist-to-advisory-committee-212710.html <![CDATA[News - QBioMed provides optimistic shareholder update ]]> https://www.proactiveinvestors.com/companies/news/212170/qbiomed-provides-optimistic-shareholder-update-212170.html Tue, 08 Jan 2019 10:08:00 -0500 https://www.proactiveinvestors.com/companies/news/212170/qbiomed-provides-optimistic-shareholder-update-212170.html <![CDATA[News - Biotech CEOs see Bristol-Myers' $74B acquisition of Celgene as a win ]]> https://www.proactiveinvestors.com/companies/news/211926/biotech-ceos-see-bristol-myers--74b-acquisition-of-celgene-as-a-win-211926.html Thu, 03 Jan 2019 11:52:00 -0500 https://www.proactiveinvestors.com/companies/news/211926/biotech-ceos-see-bristol-myers--74b-acquisition-of-celgene-as-a-win-211926.html <![CDATA[News - Q BioMed partners with SRI International to push potentially multi-bn product toward clinical trials ]]> https://www.proactiveinvestors.com/companies/news/311615/q-biomed-partners-with-sri-international-to-push-potentially-multi-bn-product-toward-clinical-trials-11615.html Thu, 13 Dec 2018 13:30:00 -0500 https://www.proactiveinvestors.com/companies/news/311615/q-biomed-partners-with-sri-international-to-push-potentially-multi-bn-product-toward-clinical-trials-11615.html <![CDATA[News - Q BioMed partners with SRI International for autism drug QBM-001 ]]> https://www.proactiveinvestors.com/companies/news/211066/q-biomed-partners-with-sri-international-for-autism-drug-qbm-001-211066.html Wed, 12 Dec 2018 09:03:00 -0500 https://www.proactiveinvestors.com/companies/news/211066/q-biomed-partners-with-sri-international-for-autism-drug-qbm-001-211066.html <![CDATA[News - Q BioMed’s Metastron acquisition ‘positive development,’ advances pipeline, says Brookline Capital Markets ]]> https://www.proactiveinvestors.com/companies/news/210227/q-biomeds-metastron-acquisition-positive-development-advances-pipeline-says-brookline-capital-markets-210227.html Thu, 29 Nov 2018 08:11:00 -0500 https://www.proactiveinvestors.com/companies/news/210227/q-biomeds-metastron-acquisition-positive-development-advances-pipeline-says-brookline-capital-markets-210227.html <![CDATA[News - Q BioMed CEO 'tremendously excited' to acquire Metastron drug from GE Healthcare ]]> https://www.proactiveinvestors.com/companies/news/311353/q-biomed-ceo-tremendously-excited-to-acquire-metastron-drug-from-ge-healthcare-11353.html Wed, 28 Nov 2018 11:29:00 -0500 https://www.proactiveinvestors.com/companies/news/311353/q-biomed-ceo-tremendously-excited-to-acquire-metastron-drug-from-ge-healthcare-11353.html <![CDATA[News - Q BioMed scores victory by acquiring cancer pain drug Metastron from GE Healthcare ]]> https://www.proactiveinvestors.com/companies/news/210137/q-biomed-scores-victory-by-acquiring-cancer-pain-drug-metastron-from-ge-healthcare-210137.html Wed, 28 Nov 2018 08:50:00 -0500 https://www.proactiveinvestors.com/companies/news/210137/q-biomed-scores-victory-by-acquiring-cancer-pain-drug-metastron-from-ge-healthcare-210137.html <![CDATA[News - Q BioMed orphan drug exec hosts roundtable on expanded access programs ]]> https://www.proactiveinvestors.com/companies/news/207970/q-biomed-orphan-drug-exec-hosts-roundtable-on-expanded-access-programs-207970.html Fri, 26 Oct 2018 15:38:00 -0400 https://www.proactiveinvestors.com/companies/news/207970/q-biomed-orphan-drug-exec-hosts-roundtable-on-expanded-access-programs-207970.html <![CDATA[News - Q BioMed plans for clinical testing with its autism drug QBM-001 ]]> https://www.proactiveinvestors.com/companies/news/310803/q-biomed-plans-for-clinical-testing-with-its-autism-drug-qbm-001-10803.html Wed, 10 Oct 2018 13:21:00 -0400 https://www.proactiveinvestors.com/companies/news/310803/q-biomed-plans-for-clinical-testing-with-its-autism-drug-qbm-001-10803.html <![CDATA[News - Q BioMed offers update on its autism drug QBM-001 ]]> https://www.proactiveinvestors.com/companies/news/206691/q-biomed-offers-update-on-its-autism-drug-qbm-001-206691.html Tue, 09 Oct 2018 09:13:00 -0400 https://www.proactiveinvestors.com/companies/news/206691/q-biomed-offers-update-on-its-autism-drug-qbm-001-206691.html <![CDATA[News - QBioMed reaches new $4M funding agreement with Yorkville Advisors Global ]]> https://www.proactiveinvestors.com/companies/news/205550/qbiomed-reaches-new-4m-funding-agreement-with-yorkville-advisors-global-205550.html Mon, 24 Sep 2018 09:03:00 -0400 https://www.proactiveinvestors.com/companies/news/205550/qbiomed-reaches-new-4m-funding-agreement-with-yorkville-advisors-global-205550.html <![CDATA[News - Q BioMed appoints ophthalmologist Dr Rajendra Apte to its advisory board ]]> https://www.proactiveinvestors.com/companies/news/205046/q-biomed-appoints-ophthalmologist-dr-rajendra-apte-to-its-advisory-board-205046.html Mon, 17 Sep 2018 10:26:00 -0400 https://www.proactiveinvestors.com/companies/news/205046/q-biomed-appoints-ophthalmologist-dr-rajendra-apte-to-its-advisory-board-205046.html <![CDATA[News - Q BioMed takes final step to gaining FDA approval to manufacture its spearhead drug ]]> https://www.proactiveinvestors.com/companies/news/310194/q-biomed-takes-final-step-to-gaining-fda-approval-to-manufacture-its-spearhead-drug-10194.html Tue, 21 Aug 2018 15:44:00 -0400 https://www.proactiveinvestors.com/companies/news/310194/q-biomed-takes-final-step-to-gaining-fda-approval-to-manufacture-its-spearhead-drug-10194.html <![CDATA[News - Q BioMed takes the final step toward FDA approval of its bone pain relief injectable ]]> https://www.proactiveinvestors.com/companies/news/203238/q-biomed-takes-the-final-step-toward-fda-approval-of-its-bone-pain-relief-injectable-203238.html Mon, 20 Aug 2018 09:43:00 -0400 https://www.proactiveinvestors.com/companies/news/203238/q-biomed-takes-the-final-step-toward-fda-approval-of-its-bone-pain-relief-injectable-203238.html <![CDATA[News - Q BioMed extends clinical trial agreement with Washington University to study glaucoma drugs ]]> https://www.proactiveinvestors.com/companies/news/309968/q-biomed-extends-clinical-trial-agreement-with-washington-university-to-study-glaucoma-drugs-9968.html Thu, 26 Jul 2018 12:05:00 -0400 https://www.proactiveinvestors.com/companies/news/309968/q-biomed-extends-clinical-trial-agreement-with-washington-university-to-study-glaucoma-drugs-9968.html <![CDATA[News - QBioMed extends clinical trial agreement to study glaucoma drugs with Washington University ]]> https://www.proactiveinvestors.com/companies/news/201568/qbiomed-extends-clinical-trial-agreement-to-study-glaucoma-drugs-with-washington-university-201568.html Wed, 25 Jul 2018 09:25:00 -0400 https://www.proactiveinvestors.com/companies/news/201568/qbiomed-extends-clinical-trial-agreement-to-study-glaucoma-drugs-with-washington-university-201568.html <![CDATA[News - Roth Capital Partners initiates coverage in Q BioMed with a Buy rating and $6.75 price target ]]> https://www.proactiveinvestors.com/companies/news/199819/roth-capital-partners-initiates-coverage-in-q-biomed-with-a-buy-rating-and-675-price-target-199819.html Thu, 28 Jun 2018 12:29:00 -0400 https://www.proactiveinvestors.com/companies/news/199819/roth-capital-partners-initiates-coverage-in-q-biomed-with-a-buy-rating-and-675-price-target-199819.html <![CDATA[News - QBioMed unveils advances in its Tie2 activating molecule for use in glaucoma treatments ]]> https://www.proactiveinvestors.com/companies/news/198381/qbiomed-unveils-advances-in-its-tie2-activating-molecule-for-use-in-glaucoma-treatments-198381.html Wed, 06 Jun 2018 09:28:00 -0400 https://www.proactiveinvestors.com/companies/news/198381/qbiomed-unveils-advances-in-its-tie2-activating-molecule-for-use-in-glaucoma-treatments-198381.html <![CDATA[News - Q BioMed takes a hands-on approach to autism research ]]> https://www.proactiveinvestors.com/companies/news/198117/q-biomed-takes-a-hands-on-approach-to-autism-research-198117.html Fri, 01 Jun 2018 10:11:00 -0400 https://www.proactiveinvestors.com/companies/news/198117/q-biomed-takes-a-hands-on-approach-to-autism-research-198117.html <![CDATA[News - Q BioMed Inc awaits FDA approval of facility to manufacture 'revenue ready' pain drug ]]> https://www.proactiveinvestors.com/companies/news/309043/q-biomed-inc-awaits-fda-approval-of-facility-to-manufacture-revenue-ready-pain-drug-9043.html Tue, 10 Apr 2018 18:49:00 -0400 https://www.proactiveinvestors.com/companies/news/309043/q-biomed-inc-awaits-fda-approval-of-facility-to-manufacture-revenue-ready-pain-drug-9043.html <![CDATA[News - Q BioMed Inc. to present at MicroCap Conference in New York City ]]> https://www.proactiveinvestors.com/companies/news/194364/q-biomed-inc-to-present-at-microcap-conference-in-new-york-city-194364.html Thu, 05 Apr 2018 11:59:00 -0400 https://www.proactiveinvestors.com/companies/news/194364/q-biomed-inc-to-present-at-microcap-conference-in-new-york-city-194364.html <![CDATA[News - Wall Street analyst kicks off Q BioMed coverage with ‘buy’ rating and punchy US$16 price target ]]> https://www.proactiveinvestors.com/companies/news/193735/wall-street-analyst-kicks-off-q-biomed-coverage-with-buy-rating-and-punchy-us16-price-target-193735.html Fri, 23 Mar 2018 16:45:00 -0400 https://www.proactiveinvestors.com/companies/news/193735/wall-street-analyst-kicks-off-q-biomed-coverage-with-buy-rating-and-punchy-us16-price-target-193735.html <![CDATA[News - Q BioMed asks FDA to approve new manufacturing facility for its cancer bone pain injection ]]> https://www.proactiveinvestors.com/companies/news/193317/q-biomed-asks-fda-to-approve-new-manufacturing-facility-for-its-cancer-bone-pain-injection-193317.html Fri, 16 Mar 2018 10:06:00 -0400 https://www.proactiveinvestors.com/companies/news/193317/q-biomed-asks-fda-to-approve-new-manufacturing-facility-for-its-cancer-bone-pain-injection-193317.html <![CDATA[News - Q BioMed to present at 30th annual Roth Conference ]]> https://www.proactiveinvestors.com/companies/news/192946/q-biomed-to-present-at-30th-annual-roth-conference-192946.html Fri, 09 Mar 2018 15:45:00 -0500 https://www.proactiveinvestors.com/companies/news/192946/q-biomed-to-present-at-30th-annual-roth-conference-192946.html <![CDATA[News - Q BioMed beefs up its board with half an eye on listing on a national exchange ]]> https://www.proactiveinvestors.com/companies/news/191653/q-biomed-beefs-up-its-board-with-half-an-eye-on-listing-on-a-national-exchange-191653.html Tue, 13 Feb 2018 16:35:00 -0500 https://www.proactiveinvestors.com/companies/news/191653/q-biomed-beefs-up-its-board-with-half-an-eye-on-listing-on-a-national-exchange-191653.html <![CDATA[News - Q Biomed gets exclusive option to license glaucoma biomarker from Washington University ]]> https://www.proactiveinvestors.com/companies/news/191410/q-biomed-gets-exclusive-option-to-license-glaucoma-biomarker-from-washington-university-191410.html Thu, 08 Feb 2018 13:36:00 -0500 https://www.proactiveinvestors.com/companies/news/191410/q-biomed-gets-exclusive-option-to-license-glaucoma-biomarker-from-washington-university-191410.html <![CDATA[News - Q BioMed pulls trigger on catalyst-rich year as it brings in US$5.48mln from offering ]]> https://www.proactiveinvestors.com/companies/news/191030/q-biomed-pulls-trigger-on-catalyst-rich-year-as-it-brings-in-us548mln-from-offering-191030.html Thu, 01 Feb 2018 15:10:00 -0500 https://www.proactiveinvestors.com/companies/news/191030/q-biomed-pulls-trigger-on-catalyst-rich-year-as-it-brings-in-us548mln-from-offering-191030.html <![CDATA[News - Q BioMed prices US$5.5mln offering as it's poised for catalyst-rich year ]]> https://www.proactiveinvestors.com/companies/news/190853/q-biomed-prices-us55mln-offering-as-it-s-poised-for-catalyst-rich-year-190853.html Tue, 30 Jan 2018 12:33:00 -0500 https://www.proactiveinvestors.com/companies/news/190853/q-biomed-prices-us55mln-offering-as-it-s-poised-for-catalyst-rich-year-190853.html <![CDATA[News - Q BioMed shares up; Corin to present at California conference ]]> https://www.proactiveinvestors.com/companies/news/189476/q-biomed-shares-up-corin-to-present-at-california-conference-189476.html Wed, 03 Jan 2018 14:48:00 -0500 https://www.proactiveinvestors.com/companies/news/189476/q-biomed-shares-up-corin-to-present-at-california-conference-189476.html <![CDATA[News - Q BioMed expects "productive and catalyst-rich" 2018 ]]> https://www.proactiveinvestors.com/companies/news/189200/q-biomed-expects-productive-and-catalyst-rich-2018-189200.html Thu, 21 Dec 2017 14:37:00 -0500 https://www.proactiveinvestors.com/companies/news/189200/q-biomed-expects-productive-and-catalyst-rich-2018-189200.html <![CDATA[News - Q BioMed says all convertible notes and loans now settled ]]> https://www.proactiveinvestors.com/companies/news/188389/q-biomed-says-all-convertible-notes-and-loans-now-settled-188389.html Wed, 06 Dec 2017 11:19:00 -0500 https://www.proactiveinvestors.com/companies/news/188389/q-biomed-says-all-convertible-notes-and-loans-now-settled-188389.html <![CDATA[News - Q BioMed Inc welcomes autism language expert to advisory committee ]]> https://www.proactiveinvestors.com/companies/news/187930/q-biomed-inc-welcomes-autism-language-expert-to-advisory-committee-187930.html Tue, 28 Nov 2017 14:38:00 -0500 https://www.proactiveinvestors.com/companies/news/187930/q-biomed-inc-welcomes-autism-language-expert-to-advisory-committee-187930.html <![CDATA[News - Q BioMed's pipeline boosted as tech partner gets funding for glaucoma therapeutic research ]]> https://www.proactiveinvestors.com/companies/news/187236/q-biomed-s-pipeline-boosted-as-tech-partner-gets-funding-for-glaucoma-therapeutic-research-187236.html Tue, 14 Nov 2017 08:39:00 -0500 https://www.proactiveinvestors.com/companies/news/187236/q-biomed-s-pipeline-boosted-as-tech-partner-gets-funding-for-glaucoma-therapeutic-research-187236.html <![CDATA[News - Q BioMed keen to get into clinic after it develops new drug candidate for toddler non-verbal disorder ]]> https://www.proactiveinvestors.com/companies/news/185894/q-biomed-keen-to-get-into-clinic-after-it-develops-new-drug-candidate-for-toddler-non-verbal-disorder-185894.html Thu, 19 Oct 2017 09:41:00 -0400 https://www.proactiveinvestors.com/companies/news/185894/q-biomed-keen-to-get-into-clinic-after-it-develops-new-drug-candidate-for-toddler-non-verbal-disorder-185894.html <![CDATA[News - Q BioMed announces favourable amendment to debenture financing ]]> https://www.proactiveinvestors.com/companies/news/185530/q-biomed-announces-favourable-amendment-to-debenture-financing-185530.html Thu, 12 Oct 2017 11:16:00 -0400 https://www.proactiveinvestors.com/companies/news/185530/q-biomed-announces-favourable-amendment-to-debenture-financing-185530.html <![CDATA[News - Q BioMed says cancer pain drug will be available later this month ]]> https://www.proactiveinvestors.com/companies/news/185139/q-biomed-says-cancer-pain-drug-will-be-available-later-this-month-185139.html Thu, 05 Oct 2017 11:19:00 -0400 https://www.proactiveinvestors.com/companies/news/185139/q-biomed-says-cancer-pain-drug-will-be-available-later-this-month-185139.html <![CDATA[News - Q BioMed strikes development deal with Sphaera Pharma to advance toddler non-verbal disorder drug ]]> https://www.proactiveinvestors.com/companies/news/184245/q-biomed-strikes-development-deal-with-sphaera-pharma-to-advance-toddler-non-verbal-disorder-drug-184245.html Tue, 19 Sep 2017 14:36:00 -0400 https://www.proactiveinvestors.com/companies/news/184245/q-biomed-strikes-development-deal-with-sphaera-pharma-to-advance-toddler-non-verbal-disorder-drug-184245.html <![CDATA[News - Biotech "accelerator" Q BioMed has several shots at goal ]]> https://www.proactiveinvestors.com/companies/news/183191/biotech-accelerator-q-biomed-has-several-shots-at-goal-183191.html Wed, 30 Aug 2017 15:13:00 -0400 https://www.proactiveinvestors.com/companies/news/183191/biotech-accelerator-q-biomed-has-several-shots-at-goal-183191.html <![CDATA[News - Q BioMed's $3mln equity financing provides runway for near term goals ]]> https://www.proactiveinvestors.com/companies/news/181862/q-biomed-s-3mln-equity-financing-provides-runway-for-near-term-goals-181862.html Wed, 02 Aug 2017 09:42:00 -0400 https://www.proactiveinvestors.com/companies/news/181862/q-biomed-s-3mln-equity-financing-provides-runway-for-near-term-goals-181862.html